Evidence map›Paper›PMID 32142096›Full record

ArticleGenetics and molecular biology2020

Three Mexican Families with β thalassemia intermedia with different molecular basis.

Lourdes Del Carmen Rizo de la Torre, Francisco Javier Perea Díaz, Bertha Ibarra Cortés, Víctor Manuel Rentería López, Josefina Yoaly Sánchez López, Francisco Javier Sánchez Anzaldo, María Teresa Magaña Torres, Katia Gonnet, Catherine Badens, Nathalie Bonello-Palot

Open access · goldAbstract read
In one paragraph

Article in Genetics and molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Lourdes Del Carmen Rizo de la TorreInstituto Mexicano del Seguro Social, Centro de Investigación Biomédica de Occidente, División de Medicina Molecular, Independencia Oriente, Guadalajara Jalisco, México.ORCID http://orcid.org/0000-0001-5482-1611
Francisco Javier Perea DíazInstituto Mexicano del Seguro Social, Centro de Investigación Biomédica de Occidente, División de Genética, Independencia Oriente, Guadalajara Jalisco, México.
Bertha Ibarra CortésUniversidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Instituto de Genética Humana "Dr Enrique Corona Rivera", Independencia Oriente, Guadalajara Jalisco, México.
Víctor Manuel Rentería LópezInstituto Mexicano del Seguro Social, Centro de Investigación Biomédica de Occidente, División de Genética, Independencia Oriente, Guadalajara Jalisco, México.
Josefina Yoaly Sánchez LópezInstituto Mexicano del Seguro Social, Centro de Investigación Biomédica de Occidente, División de Genética, Independencia Oriente, Guadalajara Jalisco, México.
Francisco Javier Sánchez AnzaldoLaboratorios Ruiz, Puebla de Zaragoza, Puebla, México.
María Teresa Magaña TorresInstituto Mexicano del Seguro Social, Centro de Investigación Biomédica de Occidente, División de Genética, Independencia Oriente, Guadalajara Jalisco, México.
Katia GonnetHôpital d' enfants de la Timone, Déparement de Génétique, Laboratoire de Génétique Moléculaire, Marseille, France.
Catherine BadensHôpital d' enfants de la Timone, Déparement de Génétique, Laboratoire de Génétique Moléculaire, Marseille, France.
Nathalie Bonello-PalotHôpital d' enfants de la Timone, Déparement de Génétique, Laboratoire de Génétique Moléculaire, Marseille, France.
Mexican Social Security Institute · MXHôpital d'Enfants · FRClínica Ruiz · MXUniversidad Autónoma de Occidente · MXUniversidad de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beta thalassemia (β-thal) is a frequent monogenic disease, is clinically and molecularly heterogeneous. This study described molecular and laboratory findings for three Mexican patients with β-thal intermedia phenotype and their relatives. Three Mexican families were studied for presenting β-thal intermedia, ARMS-PCR and Gap-PCR were performed to screen for common mutations, Sanger sequencing for rare or new alleles, and MLPA for identifying deletions and or duplications. In all three families we observed, in heterozygote condition, the mutation c.118C > T (p.Gln39*) also known as codon 39(C > T) in the β globin gene (HBB) associated with a novel molecular defect: a new duplication of the alpha globin gene cluster, a new deletion that includes the loss of exon 3 of HBB and finally a novel mutation in the 3'UTR of HBB (HBB: c.*132C > A). We report three Mexican families with beta thalassemia intermedia due to different molecular basis; a new single nucleotide mutation involving the last nucleotide of the β-globin chain transcript; and two possible new DNA rearrangements, an α cluster duplication, and a partial β gene deletion.

Identifiers

PMID32142096
PMCPMC7198011
OpenAlexW3004850167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.